Literature DB >> 8683497

Secondary amenorrhoea after total body irradiation in pre-puberty.

A Albanese1, A D Leiper, J Pritchard, R Stanhope.   

Abstract

Bone marrow transplant (BMT) has been used as part of the overall treatment of refractory malignant diseases. High dose cyclophosphamide and total body irradiation (TBI) are frequently used as conditioning for BMT. Initial regimens included a single fraction of TBI, with doses varying from 7.5-10 Gy, but this was associated with a high incidence of late sequelae including multiple endocrinopathies. A fractionated irradiation course over 3-4 days of a higher total dose, 12-15 Gy, of TBI is now used. Successfully treated patients with childhood cancer have an increased risk, of developing second tumours. We describe a patient successfully treated for AML who developed multiple endocrine dysfunction and a second benign ovarian tumour.

Entities:  

Mesh:

Year:  1996        PMID: 8683497      PMCID: PMC1295677          DOI: 10.1177/014107689608900221

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  5 in total

1.  Sclerosing stromal tumor of the ovary: A hormonal and ultrastructural analysis.

Authors:  I Damajanov; P Drobnjak; V Grizelj; N Longhino
Journal:  Obstet Gynecol       Date:  1975-06       Impact factor: 7.661

2.  Ovarian sclerosing stromal tumors. Clinicopathologic study of 10 cases.

Authors:  M Y Tang; T H Liu
Journal:  Chin Med J (Engl)       Date:  1982-03       Impact factor: 2.628

3.  Growth hormone and tumour recurrence.

Authors:  A L Ogilvy-Stuart; W D Ryder; H R Gattamaneni; P E Clayton; S M Shalet
Journal:  BMJ       Date:  1992-06-20

4.  Endocrine function following single fraction and fractionated total body irradiation for bone marrow transplantation in childhood.

Authors:  B C Thomas; R Stanhope; P N Plowman; A D Leiper
Journal:  Acta Endocrinol (Copenh)       Date:  1993-06

5.  Endocrine deficit after fractionated total body irradiation.

Authors:  A L Ogilvy-Stuart; D J Clark; W H Wallace; B E Gibson; R F Stevens; S M Shalet; M D Donaldson
Journal:  Arch Dis Child       Date:  1992-09       Impact factor: 3.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.